These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 31112044)

  • 21. PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference.
    Fani M; Del Pozzo L; Abiraj K; Mansi R; Tamma ML; Cescato R; Waser B; Weber WA; Reubi JC; Maecke HR
    J Nucl Med; 2011 Jul; 52(7):1110-8. PubMed ID: 21680701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detailed evaluation on the effect of metal ion impurities on complexation of generator eluted 68Ga with different bifunctional chelators.
    Chakravarty R; Chakraborty S; Dash A; Pillai MR
    Nucl Med Biol; 2013 Feb; 40(2):197-205. PubMed ID: 23218795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates.
    Fani M; Tamma ML; Nicolas GP; Lasri E; Medina C; Raynal I; Port M; Weber WA; Maecke HR
    Mol Pharm; 2012 May; 9(5):1136-45. PubMed ID: 22497506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of macrocyclic chelators on the targeting properties of the 68Ga-labeled gastrin releasing peptide receptor antagonist PEG2-RM26.
    Varasteh Z; Mitran B; Rosenström U; Velikyan I; Rosestedt M; Lindeberg G; Sörensen J; Larhed M; Tolmachev V; Orlova A
    Nucl Med Biol; 2015 May; 42(5):446-454. PubMed ID: 25684649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of nuclides and chelators on imaging using affibody molecules: comparative evaluation of recombinant affibody molecules site-specifically labeled with ⁶⁸Ga and ¹¹¹In via maleimido derivatives of DOTA and NODAGA.
    Altai M; Strand J; Rosik D; Selvaraju RK; Eriksson Karlström A; Orlova A; Tolmachev V
    Bioconjug Chem; 2013 Jun; 24(6):1102-9. PubMed ID: 23705574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a PACAP Peptide Analogue Labeled with (68)Ga Using Two Different Chelating Agents.
    Kumar P; Tripathi SK; Chen CP; Mehta N; Paudyal B; Wickstrom E; Thakur ML
    Cancer Biother Radiopharm; 2016 Feb; 31(1):29-36. PubMed ID: 26844850
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Satpati D; Vats K; Sharma R; Sarma HD; Dash A
    J Pept Sci; 2020 Mar; 26(3):e3241. PubMed ID: 31984553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In Vivo Characterization of 4
    Lobeek D; Franssen GM; Ma MT; Wester HJ; Decristoforo C; Oyen WJG; Boerman OC; Terry SYA; Rijpkema M
    J Nucl Med; 2018 Aug; 59(8):1296-1301. PubMed ID: 29626124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancing PET Signal at Target Tissue in Vivo: Dendritic and Multimeric Tris(hydroxypyridinone) Conjugates for Molecular Imaging of α
    Imberti C; Terry SY; Cullinane C; Clarke F; Cornish GH; Ramakrishnan NK; Roselt P; Cope AP; Hicks RJ; Blower PJ; Ma MT
    Bioconjug Chem; 2017 Feb; 28(2):481-495. PubMed ID: 27966893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 68Ga-NODAGA-RGD is a suitable substitute for (18)F-Galacto-RGD and can be produced with high specific activity in a cGMP/GRP compliant automated process.
    Pohle K; Notni J; Bussemer J; Kessler H; Schwaiger M; Beer AJ
    Nucl Med Biol; 2012 Aug; 39(6):777-84. PubMed ID: 22444238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Facile preparation of a novel Ga-67-labeled NODAGA-conjugated lactam-cyclized alpha-MSH peptide at room temperature for melanoma targeting.
    Xu J; Qiao Z; Gonzalez R; Miao Y
    Bioorg Med Chem Lett; 2020 Dec; 30(24):127627. PubMed ID: 33141072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of macrocyclic chelators on the targeting properties of (68)Ga-labeled synthetic affibody molecules: comparison with (111)In-labeled counterparts.
    Strand J; Honarvar H; Perols A; Orlova A; Selvaraju RK; Karlström AE; Tolmachev V
    PLoS One; 2013; 8(8):e70028. PubMed ID: 23936372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Theranostics of osteosarcoma and lung metastasis with new integrin α
    Sui J; Shao G; Zhang L; Zhang P; Bu T; Yao Q; Wang L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2019 Feb; 33(2):170-176. PubMed ID: 30739410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis, and preclinical evaluation of a novel bifunctional macrocyclic chelator for theranostics of cancers.
    Xu J; Cai F; Luo Z; Fan W; Dai J; Cui J; Li S; Geng C; Zheng Q; Wang Z; Tang X
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2618-2633. PubMed ID: 35347438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ⁶⁸Ga-NODAGA-VEGF₁₂₁ for in vivo imaging of VEGF receptor expression.
    Kang CM; Koo HJ; Choe YS; Choi JY; Lee KH; Kim BT
    Nucl Med Biol; 2014 Jan; 41(1):51-7. PubMed ID: 24183611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Ga-68-Labeled Fusarinine C-Based Multivalent RGD Conjugates and [(68)Ga]NODAGA-RGD-In Vivo Imaging Studies in Human Xenograft Tumors.
    Zhai C; Franssen GM; Petrik M; Laverman P; Summer D; Rangger C; Haubner R; Haas H; Decristoforo C
    Mol Imaging Biol; 2016 Oct; 18(5):758-67. PubMed ID: 26905697
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Wei X; Liu Z; Zhao Z
    Hell J Nucl Med; 2019; 22(1):78-79. PubMed ID: 30968863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [(68)Ga]NODAGA-RGD - Metabolic stability, biodistribution, and dosimetry data from patients with hepatocellular carcinoma and liver cirrhosis.
    Haubner R; Finkenstedt A; Stegmayr A; Rangger C; Decristoforo C; Zoller H; Virgolini IJ
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2005-13. PubMed ID: 27164900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noninvasive PET Imaging of a Ga-68-Radiolabeled RRL-Derived Peptide in Hepatocarcinoma Murine Models.
    Huo Y; Kang L; Pang X; Shen H; Yan P; Zhang C; Liao X; Chen X; Wang R
    Mol Imaging Biol; 2019 Apr; 21(2):286-296. PubMed ID: 29916116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increasing the Net Negative Charge by Replacement of DOTA Chelator with DOTAGA Improves the Biodistribution of Radiolabeled Second-Generation Synthetic Affibody Molecules.
    Westerlund K; Honarvar H; Norrström E; Strand J; Mitran B; Orlova A; Eriksson Karlström A; Tolmachev V
    Mol Pharm; 2016 May; 13(5):1668-78. PubMed ID: 27010700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.